Business Segments

3 Months Ended

Mar. 28, 2020

Segment Reporting [Abstract]

Business Segments

10. Business Segments

The Company operates in one segment, ophthalmology. The Company develops, manufactures and markets medical devices. Our revenues arise from the sale of consoles, delivery devices, consumables, service, and support activities.

Revenue information shown by product group is as follows:

	Three Months Ended
(in thousands)	March 28, 2020		March 30, 2019
G6	$	2,923	$	3,106
Retina		4,134		5,599
Other(1)		1,964		1,890
Total revenues	$	9,021	$	10,595
(1) Incudes service contract revenues of $315 and $308 recognized during the three months ended March 28, 2020 and March 30, 2019, respectively. Other also includes revenues from paid service, royalty, freight and legacy G probes.

Revenue information shown by geographic region, based on the sales destination, is as follows:

	Three Months Ended
(in thousands)	March 28, 2020		March 30, 2019
United States	$	4,441	$	5,202
Europe		1,984		2,477
Rest of Americas		403		618
Asia/Pacific Rim		2,193		2,298
Total revenues	$	9,021	$	10,595

Revenues are attributed to countries based on the location of end customers.

Other than the United States, Japan accounted for more than 10% of the Company’s revenues during the three months ended March 28, 2020, representing 13%. Other than the United States, no individual country accounted for more than 10% of the Company’s revenues during the three months ended March 30, 2019. The United States accounted for 49.2% and 49.1% of revenues for the three months ended March 28, 2020 and March 30, 2019, respectively. International sales accounted for 50.8% and 50.9% of revenues for the three months ended March 28, 2020 and March 30, 2019, respectively.